How to choose the first-line intensified treatment for patients with severe Kawasaki disease?

Pediatr Int. 2022 Jan;64(1):e15170. doi: 10.1111/ped.15170.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Mucocutaneous Lymph Node Syndrome* / drug therapy